Japan vs Latvia: Avoidable mortality
Avoidable mortality over time
- Japan
- Latvia
How they compare
Japan currently reports 213,167 Deaths against 8,179 Deaths in Latvia, a difference of 204,988 Deaths.
That makes Japan's figure about 26.1 times Latvia's.
Across all 24 years both countries report, Japan has been ahead every year.
Japan ranks 5th and Latvia ranks 7th of 36 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 291,384 Deaths | 14,392 Deaths | 276,993 Deaths | Japan |
| 2010s | 244,021 Deaths | 10,152 Deaths | 233,869 Deaths | Japan |
| 2020s | 216,212 Deaths | 9,799 Deaths | 206,413 Deaths | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher avoidable mortality, Japan or Latvia?
- Japan, at 213,167 Deaths against 8,179 Deaths in Latvia as of 2023.
- What is the difference in avoidable mortality between Japan and Latvia?
- 204,988 Deaths, with Japan ahead.
- How many years of comparable data are there for Japan and Latvia?
- 24 years are reported by both, from 2000 to 2023.
- How do Japan and Latvia rank globally for avoidable mortality?
- Japan ranks 5th and Latvia ranks 7th of 36 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Avoidable mortality. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents data on preventable, treatable and avoidable (preventable + treatable) causes of mortality. Preventable and treatable causes of mortality are defined as follows: - Preventable mortality: Causes of death that can be mainly avoided through effective public health and primary prevention interventions (i.e. before the onset of diseases/injuries, to reduce incidence). - Treatable (or amenable) mortality: Causes of death that can be mainly avoided through timely and effective healthcare interventions, including secondary prevention such as screening, and treatment (i.e. after the onset of diseases, to reduce case-fatality). Both indicators refer to premature mortality (under age 75). Please refer to the Sources and Methods for detailed country-specific information.